Scientists May Have Discovered Why Men’s Prostates Enlarge With Age

A New Clue to Age-Related Prostate Enlargement

Why the prostate enlarges with age remains an important question in men’s health. Growth becomes more common later in life and can narrow the urethra, disrupt bladder function, and cause bothersome urinary symptoms.

The condition is called benign prostatic hyperplasia (BPH). It is not cancer, but it can interfere with daily life and, in severe cases, prevent the bladder from emptying properly.

Researchers, including scientists associated with Johns Hopkins, have identified a previously unrecognized prostate cell population that may help explain how benign enlargement develops. The finding may also clarify why BPH tends to develop in one region rather than affecting the gland uniformly. Source 3

This is an early biological clue, not a new approved treatment. Researchers still need to determine whether these cells directly cause prostate growth, how their activity changes with age, and whether targeting them can improve symptoms.

What Is Benign Prostatic Hyperplasia?

The prostate sits below the bladder and surrounds part of the urethra, which carries urine out of the body. As the gland grows, it can compress the urethra or alter bladder contractions.

BPH does not mean that a man has prostate cancer. The two conditions develop through different biological processes, although they can occur in the same person. Urinary symptoms should not automatically be attributed to BPH or dismissed as a normal part of aging. Evaluation may also identify prostatitis, urinary infection, medication effects, bladder disorders, or neurological conditions.

Common lower urinary tract symptoms include:

• Weak or interrupted urine stream
• Difficulty starting urination
• Straining to urinate
• Frequent urination
• Sudden urgency
• Waking at night to urinate
• A feeling of incomplete emptying
• Dribbling after urination

Prostate size and symptom severity do not always match. A small enlargement can cause substantial obstruction if it affects a sensitive part of the urethra, while a larger prostate may cause few symptoms.

The Newly Reported Prostate Cell Population

Researchers reported identifying a previously unrecognized prostate cell type associated with benign enlargement. The finding may help explain why the gland grows in a characteristic region and why some tissue responds differently to aging. Source 5

Johns Hopkins researchers were also reported to have linked specific prostate cells with enlargement. Source 7

These reports describe an association, not proof of causation. The cells could contribute to enlargement, respond to existing tissue changes, or become more apparent as the prostate changes.

Their location may help explain:

• Why some prostate tissue expands while other areas remain stable
• Why local cells respond differently to aging
• How neighboring cells communicate during growth
• Which pathways encourage cell multiplication or structural change

Local hormone sensitivity, inflammation, immune activity, blood supply, and connective-tissue structure may all influence regional growth. The cells’ exact anatomical location and biological role require confirmation in peer-reviewed research and follow-up studies.

Why These Cells May Matter With Age

Aging can change how cells divide, repair tissue, respond to hormones, and communicate with neighboring cells. It can also alter immune signaling and the extracellular matrix, the structural network surrounding cells.

The newly identified cells may become more numerous, more active, or more responsive to growth signals as men age. However, available summaries do not establish whether they change before enlargement begins or whether their activity differs between men with and without BPH.

Possible areas for investigation include:

• Growth-promoting signals
• Inflammatory activity
• Communication between epithelial and stromal cells
• Blood-vessel development
• Fibrosis and connective-tissue changes
• Changes in the extracellular matrix

Androgens, including testosterone and its derivatives, also influence prostate biology. Hormonal signaling does not fully explain why BPH affects some men or particular regions. The newly identified cells could be part of a link between age-related hormonal changes and localized growth.

The most likely explanation for BPH is multifactorial. Aging, hormones, inflammation, cellular signaling, genetics, and tissue remodeling may work together.

How Researchers Study Prostate Cells

Modern molecular techniques allow scientists to study individual cells instead of analyzing an entire tissue sample as one mixture. Single-cell analysis examines gene activity within individual cells and identifies groups with distinct functions or origins.

A typical research process includes:

1. Identifying distinct prostate cell populations.
2. Determining where each population is located.
3. Comparing tissue with and without BPH.
4. Examining active genes and signaling pathways.
5. Testing cell behavior in laboratory or animal models.
6. Assessing whether changing the cells or their signals alters tissue growth.

Researchers must distinguish correlation from causation. Further studies should determine whether the cells are more abundant in BPH, change with age, appear before measurable enlargement, differ across prostate regions, and respond to signal-blocking treatments. Independent groups must also reproduce the findings in diverse patient populations.

Human studies are essential. Laboratory observations must eventually connect to meaningful outcomes, such as reduced growth, improved urine flow, fewer complications, or better quality of life.

Could This Lead to Better BPH Treatments?

Current treatments may relax prostate and bladder-neck muscles, reduce hormone-related growth, relieve obstruction, or address bladder symptoms. If the cells help drive enlargement, future therapies might target their activity or the signals they produce.

Potential strategies include:

• Blocking growth-promoting signals
• Modifying inflammatory activity
• Preventing abnormal tissue remodeling
• Interrupting communication between specific cell populations
• Targeting disease-associated cells directly

These are future possibilities. No approved therapy follows from the discovery alone. Any new treatment would require laboratory testing, clinical trials, regulatory review, and post-market safety monitoring.

Men should not start, stop, or change prescribed medication based on preliminary research.

How Doctors Evaluate an Enlarged Prostate

Evaluation may include a medical history, symptom questionnaire, physical examination, digital rectal examination, urine testing, blood tests, prostate-specific antigen testing when appropriate, urine-flow measurement, assessment of urine remaining after voiding, ultrasound, or other specialist testing.

Testing depends on age, symptoms, medical history, medications, and clinical judgment.

Seek urgent medical care for:

• Inability to urinate
• Severe lower abdominal pain
• Blood in the urine
• Fever or chills with urinary symptoms
• Severe pain during urination

These symptoms may indicate urinary retention, infection, bleeding, or another condition requiring prompt treatment.

Current BPH Treatment Options

Men with mild, stable symptoms may be monitored. Lifestyle measures can include reducing evening fluids, limiting caffeine and alcohol, double-voiding, and reviewing medicines that may worsen urinary symptoms. These measures should complement medical advice.

Common treatment categories include:

• Alpha blockers: Relax muscles in the prostate and bladder neck to improve urine flow.
• 5-alpha-reductase inhibitors: Reduce hormone-related prostate growth over time in appropriate patients.
• Other bladder medicines: Address urgency, frequency, or related symptoms in selected patients.

Procedures may be considered when symptoms are severe, complications develop, or medication is inadequate. A urologist can explain options according to prostate size, anatomy, obstruction, symptoms, and patient preference.

BPH, Prostatitis, and Prostate Cancer

Urinary symptoms can result from BPH, urinary tract infection, prostatitis, bladder conditions, medication effects, neurological disorders, or prostate cancer. Symptoms alone cannot identify the cause.

The reported cell finding concerns benign prostate enlargement. It does not show that BPH is cancerous or that these cells cause prostate cancer. BPH and prostate cancer can coexist, so men should discuss symptoms, screening, and testing with a healthcare professional.

Tadalafil and Glaucoma Risk

A separate report described a possible association between tadalafil use and increased glaucoma risk among men with enlarged prostates. Source 9

An association does not prove that tadalafil causes glaucoma. Do not stop prescribed medication without medical advice. Sudden vision changes, severe eye pain, halos around lights, nausea, or vomiting require urgent medical attention. Men with eye disease or multiple prescriptions should review medication risks with a healthcare professional.

What This Research Could Mean

The discovery could provide a clearer explanation for age-related prostate growth, new insight into regional enlargement, more precise biological targets, and potential pathways for targeted treatments. Researchers must establish the cell population’s exact function, determine whether it directly causes enlargement, and confirm the finding in independent human studies.

Treatments based on this discovery may take years to develop, if it leads to a viable therapy. The finding adds to research on hormones, inflammation, aging, and tissue signaling; it does not replace those explanations.

Conclusion

Researchers have identified a previously unrecognized prostate cell population associated with benign enlargement. The finding may help explain why the prostate grows in a specific region as men age and could guide research into targeted BPH therapies. Source 1

This remains an early research development. The cell type’s precise function is unclear, and association does not prove causation. No new approved treatment or diagnostic test follows from the discovery.

Men with persistent, worsening, or disruptive urinary symptoms should seek medical evaluation rather than wait for future therapies.

Frequently Asked Questions

Why does the prostate enlarge with age?

The exact cause is not fully understood. Aging, hormones, cellular signaling, inflammation, tissue remodeling, and genetic factors may interact. The newly identified cells could be one contributor.

Is an enlarged prostate the same as prostate cancer?

No. BPH is benign and does not mean that a man has prostate cancer. Both conditions can occur in the same person, so persistent or changing symptoms require medical assessment.

What new prostate cell type did scientists discover?

Researchers reported a previously unrecognized prostate cell population associated with enlargement. Its exact function and whether it directly causes BPH remain under investigation.

Can the discovery lead to a cure for BPH?

It could guide research into targeted treatments, but it does not provide a cure or approved therapy. Laboratory studies, human research, and clinical trials are still needed.

What are common symptoms of an enlarged prostate?

Symptoms include a weak stream, difficulty starting urination, frequent urination, urgency, nighttime urination, incomplete emptying, and dribbling. Other conditions can cause similar symptoms.

When should a man see a doctor?

Seek evaluation for persistent, worsening, or disruptive symptoms. Obtain urgent care for inability to urinate, blood in the urine, fever, chills, severe pain, or severe pain during urination.

Medical disclaimer: This article is for educational purposes and does not replace professional medical advice, diagnosis, or treatment. Discuss symptoms and medication decisions with a qualified healthcare professional.